LONDON, March 14, 2018 /PRNewswire/ --
As part of Pilatus Clinical Services ongoing plans to strengthen its positionin Europe and as part of establishing a Global footprint, the company has announced that following a recent inspection by the German regulatory authorities, its German facilities in Brandenburg have been granted a WDL/GDP
Managing Director, Philipp Hofmann says, "We have now been established and trading since April 4th 2017, but it was imperative that we are geared up to be in a position to operate under this WDL/GDP Certificate. I am proud of the dedication put in by the team to ensure that we received the go ahead from the regulatory authorities in record time."
This will greatly strengthen Pilatus Clinical Services' position in Europe and enhance its access to manufacturers and suppliers in Europe, to transform the service offered to clients.
With Brexit looming, this move will also mitigate any risk of exposure to Pilatus Clinical services and our Clients.
Management of end to end supply chain, so you don't have to worry about it. To find more out about Pilatus Clinical Services, please take a look at our website http://www.pilatusclinicalservices.com/
Contact details for PCS GMBH: +49-3328-428-9909 email@example.com http://www.pcs-deutschland.com PCS GmbH, Mahlowerstr. 249, 14513 Teltow, Amtsgericht Potsdam| HRB 30039 P | USt-IdNr. DE312595524
Subscribe to our Free Newsletters!
Exfoliative dermatitis or erythroderma is a skin condition where the skin becomes reddened and ...
Alström syndrome, a rare genetic disorder due to ALMS1 mutations, occurs in the first year of ...
Sodium zirconium cyclosilicate was approved by FDA recently to use as an oral suspension for ...View All